Old Web
English
Sign In
Acemap
>
authorDetail
>
Lynsey Womersley
Lynsey Womersley
GlaxoSmithKline
Internal medicine
Multiple myeloma
Medicine
baseline data
relapsed refractory
2
Papers
5
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Longer term outcomes with single-agent belantamab mafodotin in patients with relapsed or refractory multiple myeloma: 13-month follow-up from the pivotal DREAMM-2 study.
2021
Cancer
Sagar Lonial
Hans C. Lee
Ashraf Badros
Suzanne Trudel
Ajay K. Nooka
Ajai Chari
Al-Ola Abdallah
Natalie S. Callander
Douglas W. Sborov
Attaya Suvannasankha
Katja Weisel
Peter M. Voorhees
Lynsey Womersley
January Baron
Trisha Piontek
Eric Lewis
Joanna Opalinska
Ira Gupta
Adam D. Cohen
Show All
Source
Cite
Save
Citations (3)
Ocular Health of Patients with Relapsed/Refractory Multiple Myeloma (RRMM): Baseline Data from the DREAMM-2 Trial of Belantamab Mafodotin (Belamaf)
2020
Blood
Rakesh Popat
Aikaterini Kazantzi
Asim V. Farooq
Praneetha Thulasi
Sagar Lonial
Andrzej Jakubowiak
Ashraf Badros
Bennie H. Jeng
Joanna Opalinska
January Baron
Trisha Piontek
Julie Byrne
Lynsey Womersley
Ira Gupta
Simona Degli Esposti
Show All
Source
Cite
Save
Citations (2)
1